Mr. Jeff Zygouras reports

NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS AND ISSUANCE OF STOCK OPTIONS AND RESTRICTED SHARE UNITS

Neupath Health Inc. has released the voting results from its annual general and special meeting of shareholders held on June 14, 2023. The company has also granted stock options and restricted share units (RSUs).

The results of the election of directors are provided in an attached table.

The shareholders of the company also voted: (i) to set the number of directors of the corporation for the ensuing year at five, and that the directors be authorized to set the number of directors within the maximum and minimum numbers provided for in the articles of the corporation by way of resolution; (ii) to reappoint Ernst & Young LLP as auditor of the company for the ensuing year; and (iii) to approve the company's amended and restated stock option plan in the form attached as Schedule A to the management information circular dated April 25, 2023, prepared in connection with the meeting.

Issuance of stock options and restricted share units

On June 15, 2023, Neupath granted 296,806 stock options to non-executive directors of the company at an exercise price of 16 cents per share, with an expiry date of June 15, 2030. The options are subject to time-based vesting and will fully vest on June 15, 2024.

In addition, on June 15, 2023, the company granted 98,938 RSUs to the same non-executive directors of the company. The RSUs are subject to time-based vesting, in accordance with the policies of the TSX Venture Exchange. RSUs granted will fully vest on June 15, 2024. The terms of the RSUs are in accordance with the company's amended and restated restricted share unit plan approved by shareholders at the 2022 AGM.

Directors of the company are entitled to receive an annual equity grant as part of their compensation package. As there was no equity award made to these directors for their 2022 services, the current grant has been increased to reflect equity compensation for both the current year and the missed 2022 grant.

About Neupath Health Inc.

Neupath operates a network of health care clinics and related businesses focused on improved access to care and outcomes for patients by leveraging best-in-class treatments and delivering patient-centred multidisciplinary care. Neupath operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. In addition, Neupath provides workplace health services and independent medical assessments to employers and disability insurers through a national network of health care providers, as well as contract research services to pharmaceutical and biotechnology companies. Neupath is focused on enabling each individual it treats to live their best life.